The Foundation Dedicated to Discovering a Cure for Neuroendocrine Cancer

Caring for Carcinoid Foundation

Clinical Trials Finder

Syndicate content

The Caring for Carcinoid Foundation offers its Clinical Trials Finder and Patient Resource. This resource will provide the neuroendocrine tumor community with the most up-to-date and comprehensive information on relevant clinical trials in the United States.

With this resource, patients and caregivers may learn about the availability and purpose of existing clinical trials, and access supplemental resources from the Food and Drug Administration, the American Cancer Society and the National Cancer Institute.

By using CFCF's Clinical Trials Finder, patients and caregivers can search our comprehensive neuroendocrine tumor database of clinical trials, which consists of all active clinical trials being conducted in the US for carcinoid, pancreatic neuroendocrine tumors and pheochromocytoma.

Visit our About Clinical Trials page to learn more. For additional information on clinical trials or help using this site, please contact CFCF at 617-948-2514 or info@caringforcarcinoid.org.

Titlesort icon Phase Status Conditions State
A Pilot Study to Investigate Germ-Line MEN1 and SDHD Gene Mutation in Familial Cases of Carcinoid Cancer Carcinoid Tumor NJ
A Pilot Study to Identify Potential Imaging and Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors
Neuroendocrine Tumor
Pancreatic Neuroendocrine Tumor
NY
A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors II/III Not Recruiting Neuroendocrine Tumor CA
A Phase IIa Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors II Enrolling
Neuroendocrine Tumor
Pulmonary Carcinoid
CA
A Phase IIa Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors II Enrolling Neuroendocrine Tumor CA
A Phase II Trial of Temsirolimus and Bevacizumab in Patients With Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer II Not Recruiting
Carcinoid Tumor
Neuroendocrine Tumor
Pancreatic Neuroendocrine Tumor
Pulmonary Carcinoid
AZ
CA
CT
FL
GA
IL
IN
IA
MD
MN
MO
MT
NJ
NY
NC
OH
PA
TN
TX
VA
A Phase II Trial of Bay 43-9006 in Progressive Metastatic Neuroendocrine Tumors II Not Recruiting MN
A Phase II Study to Evaluate the Safety and Efficacy of RAD001 Plus Erlotinib in Patients With Well- to Moderately-Differentiated Neuroendocrine Tumors II Not Recruiting Neuroendocrine Tumor CA
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors II Enrolling Pancreatic Neuroendocrine Tumor
CA
FL
A Phase II Study of Axitinib in Advanced Carcinoid Tumors II Not Recruiting Carcinoid Tumor
CA
FL
A Phase II Study Evaluating the Efficacy and Safety of Ultratrace Iobenguane I 131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma II Not Recruiting Pheochromocytoma
CA
FL
IA
LA
MD
MO
NY
NC
PA
RI
TX
A Phase II Clinical Trial of Cisplatin + Gemcitabine HCl (GEM) + Low-Dose Metronomic Interferon-a (IFN-a) Combined With Fever-Range Whole-Body Thermal Therapy (FR-WB-TT) in Patients With Metastatic/or Locally Advanced Malignancies (Small-Cell Lung Cancer, Neuroendocrine Cancer, Gastric Cancer) II Enrolling
Neuroendocrine Tumor
Pulmonary Carcinoid
TX
A Phase II Clinical and Translational Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET) II Not Recruiting
Carcinoid Tumor
Neuroendocrine Tumor
Pancreatic Neuroendocrine Tumor
NY
A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors I/II Enrolling Pancreatic Neuroendocrine Tumor MO
A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET) I/II Enrolling Pancreatic Neuroendocrine Tumor
IL
MI
PA
TN
A Phase I/II Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer (Phase I) or Advanced Colorectal Cancer (Phase II) I/II Not Recruiting
Carcinoid Tumor
Neuroendocrine Tumor
Pancreatic Neuroendocrine Tumor
Pulmonary Carcinoid
TN
A Phase I-II Study Evaluating the Maximum Tolerated Dose, Dosimetry, Safety, and Efficacy of Ultratrace Iobenguane I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma I/II Not Recruiting Pheochromocytoma
IA
MD
MI
MO
NY
NC
PA
RI
A Phase I, Open-Label, Dose Escalation Study of Daily Dosing With BB-10901 I Not Recruiting Neuroendocrine Tumor TX
A Phase I, Open Label, Maximum Tolerated Dose-Finding Study to Evaluate the Safety and Tolerability of 90Y-DOTA-tyr3-Octreotide Administered by Intravenous Infusion to Children With Refractory Somatostatin-Receptor Positive Tumors I
Carcinoid Tumor
Pheochromocytoma
IA
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease I Not Recruiting Carcinoid Tumor
CA
FL
TX
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs) I Enrolling Neuroendocrine Tumor
CA
FL
MA
TX
A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors I Not Recruiting
Neuroendocrine Tumor
Pancreatic Neuroendocrine Tumor
Pulmonary Carcinoid
MN
A Phase I Trial of Nelfinavir (Viracept®) in Adults With Solid Tumors I
Carcinoid Tumor
Neuroendocrine Tumor
Pheochromocytoma
Pulmonary Carcinoid
MD
A Phase I Trial of BAY 43-9006 (Sorafenib) and Bevacizumab in Refractory Solid Tumors With Biologic and Proteomic Analysis I Not Recruiting Neuroendocrine Tumor MD
A Phase I Study of 1-methyl-D-tryptophan (D-1MT) in Patients With Relapsed or Refractory Solid Tumors I
Carcinoid Tumor
Neuroendocrine Tumor
TN

Tell Your Story

Get the facts on pancreatic neuroendocrine cancer

Sign-up for our e-Newsletter.

Tell Your Story

video

Latest Video

Check out the CFCF video library.

Sign-up for our e-Newsletter.

Nancy

Ron's Blog

Read the latest blog from CFCF's Executive Director.

video

Latest Video

Check out the CFCF video library.

Lauren

Lauren's Blog

Read the latest blog from CFCF's Director of Research.

Nancy

Ron's Blog

Read the latest blog from CFCF's Executive Director.

Connect with CFCF online:
FacebookTwitterYouTube

Lauren

Lauren's Blog

Read the latest blog from CFCF's Director of Research.

Seal Exchange      

Connect with CFCF online:
FacebookTwitterYouTube

Seal Exchange